Back to Articles
Market Analysis2026-06-27 07:04:5710 min

Iran Strikes and Rotation: Week in Review

Weekly review of Iran strikes, market rotation into small caps and defensives, and lessons from four closed research subjects. What the data showed this week.

Iran Strikes and Rotation: Week in Review

The last time conditions loosely resembled this week was Q4 2018, when the Fed was tightening into softening data while trade war threats escalated and geopolitical tension in the Middle East kept energy markets on edge. Back then, the S&P 500 fell roughly 20% in a quarter before reversing sharply once the Fed pivoted. The parallel is imperfect, obviously. We are not in the same rate-hiking posture, and the geopolitical situation is different in kind. But the texture is similar: a market trying to price in two competing forces at once, defensive rot

Iran Strikes and Rotation: Week in Review

The last time conditions loosely resembled this week was Q4 2018, when the Fed was tightening into softening data while trade war threats escalated and geopolitical tension in the Middle East kept energy markets on edge. Back then, the S&P 500 fell roughly 20% in a quarter before reversing sharply once the Fed pivoted. The parallel is imperfect, obviously. We are not in the same rate-hiking posture, and the geopolitical situation is different in kind. But the texture is similar: a market trying to price in two competing forces at once, defensive rotation pulling one way and risk appetite pulling the other.

This week, the defining tension was a Strait of Hormuz attack triggering US strikes on Iran, all while domestic rotation underneath the surface was quietly reshuffling where money is going.

What the Week Revealed

The headline that anchored everything was the US striking Iran in response to an attack on a cargo ship in the Strait of Hormuz. This came barely ten days after the two sides reached a memorandum of understanding on June 17. As I wrote in the Hormuz Attack, Asia Tech Selloff: Friday Breakdown post on June 26, the fragility of that ceasefire was already being tested. Now we know it did not hold.

But here is what is interesting: the week's market data did not reflect a simple, uniform risk-off move. The S&P 500 ended essentially flat, down just 0.01%. The Nasdaq slipped 0.46%. Meanwhile, small caps in the Russell 2000 gained 0.71%, and European indexes were broadly higher, with the DAX up 1.03%, the FTSE gaining 0.65%, and the Euro Stoxx 50 up 0.85%. Japan's Nikkei rose 4.61%. South Korea's KOSPI was up a remarkable 5.42%.

Perhaps the most telling single data point: the VIX ended the week at 18.89, still below 20. In a week where the US launched strikes on Iran, a sub-20 VIX tells you the options market was not pricing in systemic contagion. That is powerful evidence that this was rotation, not panic.

That is not the shape of a market gripped by geopolitical fear. It is the shape of a market rotating.

Why Japan and Korea Surged

The Nikkei's 4.61% and the KOSPI's 5.42% gains were the most dramatic moves of the week and deserve explanation. For Japan, the story is partly yen-driven: continued yen weakness against the dollar makes Japanese exporters more competitive and mechanically boosts their earnings in yen terms. The Bank of Japan's dovish posture relative to other central banks continues to support equity inflows. For Korea, the semiconductor cycle is the key driver. Korean chipmakers are direct beneficiaries of global AI infrastructure spending, and the rotation out of US large-cap tech does not mean rotation away from the semiconductor supply chain. Capital leaving Nasdaq names can flow into the companies that actually manufacture the chips those US firms depend on. VEA, the developed international markets ETF, gained 1.25% on the week, confirming the broader ex-US bid.

The Noise Layer: Tariffs, China, and SpaceX

Layer in the other headlines. Trump threatened a 100% tariff on European nations over tech taxes. That threat kept big US tech names under pressure: the Nasdaq's 0.46% weekly decline came even as the S&P 500 was flat, which tells you where the selling pressure was concentrated.

China's May industrial profits data showed factories and exports staying resilient even as domestic demand softened. The confirmed headline, "China's May industrial profits slow as exports offset weak demand," captures the tension precisely. Factories are humming on export strength, but the domestic consumer remains weak. That mixed picture directly explains why China-focused ETFs struggled: the export resilience was not enough to offset concerns about the consumer. VWO, the emerging markets ETF, fell 0.29% while the Hang Seng dropped 1.43%. Meanwhile, China stripped generals and a former financial regulator of their posts, which speaks to internal political tightening in Beijing, adding another layer of governance uncertainty for investors in Chinese equities.

And then there is SpaceX joining the Nasdaq 100 on July 7. This is directly relevant to the tech rotation discussion. When a private-turned-public mega-cap enters the index, passive funds tracking QQQ must buy it, which means selling existing constituents to make room. That rebalancing pressure could add to the headwinds already facing concentrated large-cap tech names. It is one more structural force pushing in the direction the rotation is already heading.

What the week really showed is that beneath the geopolitical noise, capital has been sorting itself: out of concentrated large-cap tech, into small caps, healthcare, and international developed markets.

What the Agent Got Right, and What It Got Wrong

Let me be direct about the misses first, because that is the honest part of this exercise.

The agent closed four research subjects this week, all as negative observed outcomes. MU (Micron) hit its stop loss at negative 7.25%. MSFT (Microsoft) was closed at negative 6.47% after its confidence score dropped below the gate. META was closed at negative 5.19% after compounding losses across multiple reviews. And EWJ (iShares Japan ETF) was closed at negative 3.65%, also via the confidence gate.

Here is the pattern: three of the four were large-cap tech or tech-adjacent names entered while the agent had relatively moderate confidence. The research history shows this clearly. Entries below 0.65 confidence have historically produced a high loss rate. Across 34 closed research sets, the hit rate in the 0.55 to 0.70 confidence band is only 38%. The system is getting better at identifying these weak setups and closing them, but the lesson keeps repeating: the confidence gate is not a suggestion, it is a filter.

The EWJ exit stings a little extra given that the Nikkei rallied 4.61% this week, but the exit happened on June 24 before that move. Timing matters.

On the positive side, the rotation thesis is playing out across several active research subjects. IWM, the Russell 2000 ETF, is now showing a 4.84% positive observed delta since entry. The thesis there was built on rate-sensitive small caps benefiting from a positive yield curve and mid-cycle expansion conditions. IWM gained 0.75% this week alone. That said, the agent's confidence on IWM is low at 33%, and the health review flagged minor concerns, noting that if the broad market selloff deepens, small caps could give back gains quickly. I am watching this one closely. Just because the delta looks good today does not mean the thesis is proven.

XLF, the Financial Select Sector ETF, sits at a 2.2% positive delta from entry. The broader thesis of relative outperformance during volatility remains intact. The yield curve steepening dynamic and solid bank earnings growth support the original entry logic.

Healthcare: The Exception That Proves the Rule

One of the agent's hardest-won lessons is that healthcare value traps are a persistent blind spot. Five out of six healthcare entries built on low PE and high dividend yield have been negative outcomes. The one exception was LLY (Eli Lilly), which succeeded because it had genuine hypergrowth characteristics: GLP-1 driven revenue growth and triple-digit earnings acceleration.

This week, LLY sits at a small negative delta of 0.47%, essentially flat. The thesis remains intact with a 5 out of 5 health verdict. GILD (Gilead Sciences) is similarly flat at 0.06% delta, also with a healthy thesis review. The critical distinction for both is that they were not entered as defensive yield plays. GILD was entered on a combination of strong margins, high ROE, and robust earnings growth well above the threshold where the agent's healthcare entries have historically worked. That distinction, growth versus value within healthcare, continues to matter.

The Quiet Strength in Defensives and Quality

PG (Procter and Gamble) advanced to a 1.34% positive delta, and its thesis is one of the cleaner reads in the active set. In a week where geopolitical headlines dominated and tech names were under pressure, PG did what the thesis expected: it held up. The original entry noted PG rallied 4.1% in a prior week when the S&P 500 fell 2.6%, demonstrating classic defensive rotation. That pattern repeated this week in miniature.

V (Visa) is at 1.0% positive delta, quietly compounding. As an asset-light payments network, Visa is less sensitive to the credit cycle stress that might weigh on traditional banks, and its net margins north of 50% give it a quality profile that tends to attract capital during uncertain periods. The thesis remains intact.

ADBE (Adobe) is the outlier and, honestly, the one that concerns me most. It is sitting at negative 5.2% since entry. The thesis was built on a significant valuation dislocation relative to its free cash flow generation. The market appears to be pricing in meaningful AI disruption risk for Adobe's creative software franchise, and this week's tariff threat against European tech taxes added another layer of uncertainty for US tech broadly. The health review still shows the thesis intact at 5 out of 5, but the delta is uncomfortable. If the market is right about AI disruption, the compressed multiple is justified, not a mispricing. That is the risk.

A reminder: everything discussed here is observational research, not personalized advice. Anyone considering decisions based on these observations should consult an authorized financial advisor.

What to Carry Into Next Week

The thing I keep coming back to is the divergence. The S&P 500 was flat. The Nasdaq slipped. But small caps, international developed markets, Japan, and Korea were all meaningfully higher. That is not a market breaking down. It is a market reorganizing.

The primary driver of this rotation appears to be the combination of tariff pressure on US large-cap tech and the relative attractiveness of international equities where currencies and earnings cycles are aligned more favorably. The geopolitical situation with Iran adds genuine uncertainty around energy prices and the Strait of Hormuz chokepoint, but the sub-20 VIX tells us the market is treating this as a regional risk, not a systemic one.

The Iran situation matters most for oil. As I discussed in Oil Falls to Prewar Levels: What It Means Now, the oil market had been unwinding its geopolitical premium. This week's strikes test whether that unwinding continues or reverses. That is the question the agent is watching most closely heading into Monday.

The SpaceX addition to the Nasdaq 100 on July 7 adds a mechanical rebalancing dynamic that could amplify selling pressure in existing mega-cap tech names. Worth watching alongside the broader rotation story.

The broader lesson from this week, and from the four closed research subjects: the agent's confidence scoring works as a filter, but only if it is respected. The system is learning. Slowly, sometimes painfully, but it is learning.

Research output, not investment advice. The material above is observational and educational. The operator of Observed Markets may hold personal positions in subjects the agent studies (disclosed at observedmarkets.com/conflicts-of-interest). Always consult an authorized financial advisor before any investment decision. Past observed outcomes do not predict future results.